deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

FARMAFORCE LIMITED (ASX.FFC)

Now called: A.C.N. 167 748 843 LIMITED

ASX Announcements (courtesy of ASX)

20152016201720182019202020212022

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
Former (or subsequent) names

 

Shareholder links
Our website ranking of FFC: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Boardroom Pty Ltd
Level 8, 210 George Street, Sydney NSW 2000
Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details
ISIN: AU000000FFC7
Address: Level 9 85 Castlereagh St Sydney NSW 2000
Tel:  02 8239 5400

Date first listed: 27/10/2015

Sector: Health Care Equipment & Services
Industry Group: XHJ

company is now called A.C.N. 167 748 843 LIMITED

05/11/2023

delisted following failure to pay the annual ASX listing fees per Listing Rule 17.15

29/08/2022

we understand the company failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023

29/08/2022

Under Listing Rule 17.6, an entity (if not already suspended) that had not paid its annual listing fees by close of business on Friday, 19 August 2022 would have its securities suspended from Official Quotation before the commencement of trading on Monday, 22 August 2022. The following entity has failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023, and each entity's securities are already suspended from quotation. Under Listing Rule 17.15, any entity that has not paid its annual listing fees as required by Listing Rule 16.5 by 5.00 pm AEST on Friday, 26 August 2022 will be removed from the Official List with effect from the close of trading on Friday, 26 August 2022.

22/08/2022

Mark Robinson, Antony Resnick and Riad Tayeh were appointed Joint and Several Administrators of the above company on 10 March 2022. On 11 July 2022 creditors resolved to place the company into liquidation. The likelihood of a return to shareholders is remote and depends primarily on the total amount of creditors' claims and our investigations into the Company's financial affairs.

29/07/2022

this company, now in liquidation, is called ACN 167 748 843 - apparently the company's business was sold around the same time a change of company name occurred - (3 June 2022 - courtesy of AFR "Arrotex Pharmaceuticals, backed by AFR Rich Lister Dennis Bastas, has snapped up Farmaforce from the administrators of failed controversial biotech iQ Group Global. The administrators at De Vries Tayeh also confirmed that offers had been made for a yacht that the biotechnology outfit had bought for $1.2 million.")

19/07/2022

Mark Robinson and Anthony Resnick of de Vries Tayeh are appointed liquidators

11/07/2022

The company has entered voluntary administration with the directors appointing Mark Robinson, Anthony Resnick, and Riad Tayeh of de Vries Tayeh as joint and several voluntary administrators.

11/03/2022

The audit review of its half-year report for the six months ended 31 December 2021 has not yet been completed. The Company is working with its auditor to complete the review and the Company expects to release its audited halfyear report on Monday 7 March 2022.

01/03/2022

The company's securities will be suspended from official quotation from the commencement of trading today, 1 March 2022, following its failure to lodge the relevant periodic report by the due date.

01/03/2022

listed entity carried for record purposes only

27/10/2015
View ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    12/12/2020Con Tsigounis220,000$0.085$18,700
    11/12/2020George Elias220,000$0.085$18,700
    11/12/2020Harry Simeonidis108,471$0.085$9,220
    11/12/2020Con Tsigounis220,000$0.085$18,700
    30/11/2020Harry Simeonidis55,800$0.085$4,743

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    Vincenzo MilazzoNon Exec Chairman17/06/2021
    Terence RegoNon Exec Director22/03/2021
    Con TsigounisDirector24/06/2015
    Kosmas DimitriouCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)
    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    George SyrmalisNon Exec Director24/11/201523/11/2021
    Harry SimeonidisExecutive Director14/08/201730/08/2021
    George EliasNon Exec Chairman04/04/201517/06/2021
    Stamatia ToliasIndependent Director02/04/201514/08/2017
    Daniel MoratoExecutive Director07/04/201523/11/2015

    Date of first appointment, title may have changed.